The challenge of identifying family carers in general practice at an early stage and measuring their burden: A scoping review of possible tools and their actual use.

J Family Med Prim Care

Center of Health Sciences, Medical Faculty, Institute of General Practice and Family Medicine, Martin-Luther-University Halle-Wittenberg, Magdeburger Straße 8, 06112 Halle (Saale), Germany.

Published: September 2024

Informal care, provided unpaid by family members or friends is a crucial source for providing care at home due to chronic illnesses, disability, or long-lasting health issues. An increasing burden on informal carers largely determines the already proven negative mental and physical health effects. General practitioners are usually responsible for recognizing the effects of persistent burdens on informal carers at an early stage to maintain a functional caring relationship by providing individual support. A scoping review was conducted in four databases (PubMed, LIVIVO, Cochrane Library, and Cumulative Index to Nursing and Allied Health Literature [CINAHL]) until July 31, 2023, to identify studies describing the actual use of tools to identify informal care and measure the burden due to informal care. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews (PRISMA-ScR) guidelines were followed to select studies. A total of 5.686 references were identified, and 59 potentially eligible articles were assessed for inclusion, resulting in the inclusion of five studies published between 2009 and 2019. Instruments were primarily used to measure burden after an intervention; only one study focused on instruments to identify carers in general practice. This review highlights the need for a tool to identify informal carers in general practice, but it is important to consider practice-specific processes and settings. Future research should take a proactive approach to testing, modifying, and implementing an assessment and optimizing framework conditions. A follow-up project should be initiated to evaluate the effectiveness of an adapted identification tool on the burden and health of family carers.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11504783PMC
http://dx.doi.org/10.4103/jfmpc.jfmpc_551_24DOI Listing

Publication Analysis

Top Keywords

carers general
12
general practice
12
informal care
12
informal carers
12
family carers
8
early stage
8
scoping review
8
burden informal
8
identify informal
8
measure burden
8

Similar Publications

Basic Science and Pathogenesis.

Alzheimers Dement

December 2024

Cure MAPT FTD, Denver, CO, USA.

Dementia was a condition I was aware of from a very young age as I witnessed my grandmother decline, and my mother step into the role as a caregiver, health care director and power of attorney. I was taught the foundation for this process by direct observation of my mother's actions. One aspect of caregiving that isn't teachable is the emotional pain, anguish, sadness and guilt that often accompanies that role.

View Article and Find Full Text PDF

Basic Science and Pathogenesis.

Alzheimers Dement

December 2024

Cure MAPT FTD, Sarasota, FL, USA.

My beloved husband, Robert Steel, died at 58 from MAPT FTD, a disease that stretches back through his family's generations. Before we married he told me his father died of early-onset Alzheimers and he was terrified he would inherit that disease. In his early 50s he began exhihibiting symptoms that I attributed to stress-his work as a respected high school teacher began to slip, he began to lose the ability to have a visual map in his head, he began to repeat stories, his behavior became more compulsive, forgot how he was related to a favorite cousin.

View Article and Find Full Text PDF

Clinical Manifestations.

Alzheimers Dement

December 2024

Universidad Santa Maria La Antigua, Panama, Panama.

Background: Dementia affects nearly 50 million people worldwide and is the leading cause of disability in older adults. According to predictions by the World Health Organization, the global population with dementia will reach 82 million by 2030, and 152 million by 2050. Currently, pharmacological interventions to delay cognitive decline are proving to be insufficient.

View Article and Find Full Text PDF

Background: Individuals with Down syndrome (DS) typically develop Alzheimer's disease (AD) at an early age. Estimates of the age of decline vary, but typically place it in the early-mid 50s. As AD onset can be difficult to identify in intellectually impaired cohorts, understanding the expected timing of decline may help individuals and caregivers prepare.

View Article and Find Full Text PDF

Clinical Manifestations.

Alzheimers Dement

December 2024

Hotchkiss Brain Institute, University of Calgary, Calgary, AB, Canada.

Background: Apathy may appear as a less acute late-life syndrome; however, it is associated with accelerated progression to dementia and contributes to adverse outcomes for patients and caregivers. These findings are not surprising since apathy can cause individuals to forego activities that improve cardiovascular and cognitive health (e.g.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!